GenPep R&D facility is currently located at NCL Venture Canter Pashan Pune, Maharashtra. The present facility is aimed to develop a comprehensive product portfolio of generic Peptides and APIs which are used in several chronic therapy areas such as cancer, diabetes, cardiovascular, hypertension, and Osteoporosis for the Indian as well as the regulatory market. The current facility is capable to manufacture and analyse the generic as well as novel peptides and Oligonucleotides, nucleosides from mg to gm scale.